Urate oxidase in the prophylaxis or treatment of hyperuricemia: The United States experience
- 31 October 2001
- journal article
- Published by Elsevier in Seminars in Hematology
- Vol. 38, 13-21
- https://doi.org/10.1016/s0037-1963(01)90039-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Tumor lysis syndrome: pathogenesis and managementPediatric Nephrology, 1995
- Molecular evolution of the urate oxidase-encoding gene in hominoid primates: nonsense mutationsGene, 1991
- Renal dysfunction and hyperuricemia at presentation and relapse of acute lymphoblastic leukemiaMedical and Pediatric Oncology, 1990
- Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: Relationship to acute renal failureThe Journal of Pediatrics, 1986
- Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemiaThe Journal of Pediatrics, 1982
- Acute tumor lysis syndrome: A review of 37 patients with Burkitt's lymphomaThe American Journal of Medicine, 1980
- Nephropathy, xanthinuria, and orotic aciduria complicating Burkitt's lymphoma treated with chemotherapy and allopurinolMetabolism, 1972
- Xanthine Nephropathy in a Patient with Lymphosarcoma Treated with AllopurinolNew England Journal of Medicine, 1970
- Prevention and management of acute hyperuricemia in childhood leukemiaThe Journal of Pediatrics, 1968
- Use of Allopurinol for Prevention and Control of Hyperuricemia in Patients with Neoplastic DiseaseNew England Journal of Medicine, 1966